河北医科大学学报

• 论著 • 上一篇    下一篇

微小RNA92a联合胃蛋白酶原在胃癌中的诊断价值

  

  1. 河北医科大学第一医院消化内科,河北 石家庄 050031
  • 出版日期:2017-06-25 发布日期:2017-06-22
  • 作者简介:牛巍巍(1981-),男,河北南宫人,河北医科大学第一医院主治医师,医学博士研究生,从事消化内科疾病诊治研究。
  • 基金资助:
    河北省医学科学研究重点课题(ZD20140221)

The diagnostic value of miRNA92a combined with micro pepsinogen in gastric carcinoma

  1. Department of Gastroenterology, the First Hospital of Hebei Medical
    University, Shijiazhuang 050031, China
  • Online:2017-06-25 Published:2017-06-22

摘要: [摘要]目的探讨微小RNA(microRNA,miRNA)92a联合胃蛋白酶原(pepsinogen,PG)在胃癌诊断中的价值及临床意义。方法选择胃癌患者60例,慢性萎缩性胃炎患者141例,慢性非萎缩性胃炎患者162例,采用实时荧光定量PCR检测miRNA92a,胶体金免疫层析法检测PG,分别计算miRNA92a、PG以及miRNA92a联合PG对胃癌诊断的敏感度及特异度。结果胃癌组血浆miRNA92a表达量高于慢性萎缩性胃炎组和非萎缩性胃炎组,慢性非萎缩性胃炎组血浆miRNA92a表达量低于慢性萎缩性胃炎组(P<005)。胃癌组血浆 PGⅠ和PGⅠ/PGⅡ均低于慢性萎缩性胃炎组和慢性非萎缩性胃炎组,慢性萎缩性胃炎组PGⅠ/PGⅡ低于慢性非萎缩性胃炎组(P<005);慢性萎缩性胃炎和慢性非萎缩性胃炎PGⅠ比较差异无统计学意义(P>005)。miRNA92a诊断胃癌的敏感度和特异度分别为85.70%和70.8%;PG诊断胃癌的敏感度和特异度分别为75.80%和84.90%;miRNA92a联合PG诊断胃癌的敏感度和特异度分别为86.49%和89.32%。结论miRNA92a联合PG检测诊断胃癌的效能优于单一检测。

关键词: 胃肿瘤, 微RNAs, 胃蛋白酶原

Abstract: Abstract]  ObjectiveTo investigate the value of microRNA92a combined with pepsinogen(PG) in the diagnosis of gastric carcinoma. MethodsSixty cases of gastric cancer, 141 cases of chronic atrophic gastritis and 162 cases of chronic nonatrophic gastritis were adopted,using realtime PCR assay for detection of micro RNA92a and using immune colloidal gold technique for measuring PG. The sensitivity and specificity of miRNA92a, PG and miRNA92a combined with PG in the diagnosis of gastric cancer were calculated respectively. ResultsThe expression of miRNA92a in chronic atrophic gastritis group and non atrophic gastritis group was lower than gastric cancer group. The expression level of plasma miRNA92a in chronic non atrophic gastritis group was lower than chronic atrophic gastritis group(P<005). The expression level of PG Ⅰ and PG Ⅰ/PGⅡ in gastric cancer group were lower than chronic atrophic gastritis group and chronic non atrophic gastritis group. The value of PG Ⅰ/PGⅡ in chronic atrophic gastritis group was lower than non atrophic gastritis group(P<005). There was not significant between chronic atrophic gastritis and chronic atrophic gastritis group(P>005). microRNA92a sensitivity in the diagnosis of gastric cancer and specificity were 85.70% and 70.8%. PG in sensitivity and specificity in the diagnosis of gastric cancer were 75.80% and 84.90%. The sensitivity of micro RNA92a combined with PG diagnosis of gastric cancer and precancerous lesion and the specificity was 86.49%, the specificity was 89.32%. Conclusionmicro RNA92a combined with PG was better than single detection in diagnosis of gastric cancer.

Key words: stomach neoplasms, microRNAs, pepsinogen